Loading clinical trials...
Loading clinical trials...
Expressive Writing Among Chinese Breast Cancer Survivors: Study One
This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
The study examines the potential health benefits (i.e., physical health, psychological health, and quality of life) of this expressive writing intervention for Chinese-speaking breast cancer survivors. The study also explores the mechanism through which expressive writing confers health benefits and investigates who will benefit most from the expressive writing intervention. Chinese-speaking breast cancer survivors who have completed primary treatment will be randomly assigned to a control writing condition, a self-regulation condition, or an emotional disclosure writing condition. Health outcomes are assessed at baseline, and 1, 3, and 6 months follow-ups. Mixed qualitative-quantitative mixed methods are used to explore the effect of the intervention on health outcomes and explore the mechanisms that explain the benefits of this intervention.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Herald Cancer Association
Los Angeles, California, United States
University of Houston
Houston, Texas, United States
Start Date
July 1, 2009
Primary Completion Date
October 1, 2011
Completion Date
October 1, 2011
Last Updated
September 4, 2019
96
ACTUAL participants
Self-Regulation Condition
BEHAVIORAL
Emotional Disclosure Condition
BEHAVIORAL
Lead Sponsor
University of Houston
Collaborators
NCT04704661
NCT05372640
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions